Timber Pharmaceuticals, Inc. (TMBR) Financial Statements (2024 and earlier)

Company Profile

Business Address 3 MOUNTAINVIEW ROAD, SUITE 100
WARREN, NJ 07059
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
1/31/2020
1/31/2019
1/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments9,08016,80910,3497273,0697,576
Cash and cash equivalents9,08016,80910,3497273,0697,576
Receivables     47
Inventory, net of allowances, customer advances and progress billings      10
Inventory      10
Prepaid expense526     
Other current assets207310377   
Other undisclosed current assets    259312388
Total current assets:9,81317,11910,7269863,3857,981
Noncurrent Assets
Operating lease, right-of-use asset316639787 
Property, plant and equipment1916 93148109
Deposits noncurrent assets128128115   
Other noncurrent assets    115121 
Other undisclosed noncurrent assets    936  
Total noncurrent assets:4637839021,144269109
TOTAL ASSETS:10,27617,90111,6282,1303,6548,090
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1,6108517691,5062,2972,979
Accounts payable1,3519533955641,3631,376
Accrued liabilities1,6108517699429341,603
Other undisclosed accounts payable and accrued liabilities(1,351)(953)(395)   
Debt    178  
Other undisclosed current liabilities3,4323,342613   
Total current liabilities:5,0414,1921,3811,6842,2972,979
Noncurrent Liabilities
Long-term debt and lease obligation  369617   
Long-term debt, excluding current maturities  3838   
Liabilities, other than long-term debt 7411224 39
Deferred income tax liabilities   38 
Other liabilities  747424  
Operating lease, liability 331579 
Derivative instruments and hedges, liabilities      39
Other undisclosed noncurrent liabilities    76159 
Total noncurrent liabilities: 4437297855939
Total liabilities:5,0414,6352,1102,4692,3563,018
Equity
Equity, attributable to parent5,23413,2677,608(339)1,2985,072
Common stock148642715218160
Additional paid in capital53,35042,08825,82687,86779,61466,190
Accumulated deficit(48,264)(28,885)(18,245)(88,221)(78,534)(61,278)
Other undisclosed equity   1,910   
Total equity:5,23413,2679,518(339)1,2985,072
TOTAL LIABILITIES AND EQUITY:10,27617,90111,6282,1303,6548,090

Income Statement (P&L) ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
1/31/2020
1/31/2019
1/31/2018
Revenues83887454 5773
Revenue, net73
Sublease income 425207 
Cost of revenue
(Cost of Goods and Services Sold)
     (83)(250)
Gross profit:83887454 (26)(177)
Operating expenses(19,319)(11,537)(20,666)(9,686)(16,480)(16,699)
Other undisclosed operating income      
Operating loss:(19,235)(10,650)(20,212)(9,686)(16,506)(16,876)
Nonoperating income (expense)(136)(19)5,132(290)(778)(126)
Gain (loss), foreign currency transaction, before tax(23)(4)16   
Other nonoperating expense(153)(16)(3,600)(290)(778)(126)
Loss from continuing operations before equity method investments, income taxes:(19,372)(10,669)(15,080)(9,976)(17,284)(17,002)
Other undisclosed income from continuing operations before income taxes    29128364
Loss from continuing operations before income taxes:(19,372)(10,669)(15,080)(9,685)(17,256)(16,638)
Income tax expense (benefit) (8)30(38)(2)(2)(2)
Other undisclosed loss from continuing operations      
Loss from continuing operations:(19,379)(10,639)(15,118)(9,687)(17,258)(16,640)
Loss before gain (loss) on sale of properties:(10,639)(15,118)(9,687)(17,258)(16,640)
Net loss attributable to parent:(19,379)(10,639)(15,118)(9,687)(17,258)(16,640)
Preferred stock dividends and other adjustments   (53)   
Other undisclosed net loss available to common stockholders, basic  (130)(91)   
Net loss available to common stockholders, diluted:(19,379)(10,769)(15,261)(9,687)(17,258)(16,640)

Comprehensive Income ($ in thousands)

6/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
1/31/2020
1/31/2019
1/31/2018
Net loss:(19,379)(10,639)(15,118)(9,687)(17,258)(16,640)
Comprehensive loss, net of tax, attributable to parent:(19,379)(10,639)(15,118)(9,687)(17,258)(16,640)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: